Fig 1.
Flow chart of the patients’ inclusion criteria.
Table 1.
Demographic characteristics of HIV patients receiving ART by BMI groups.
Fig 2.
Immune recovery and growth in different BMI categories during 8-year ART treatment.
(A) shows immune recovery by BMI categories from the start of ART to the 8th year of follow-up; (B) shows Mean increase in CD4 cell count from the start of ART to the 8th year of follow-up.
Table 2.
Univariate and multivariate analysis of CD4 changes at different time points of antiretroviral therapy.
Fig 3.
Kaplan-Meier survival curves of patients with different BMI categories (underweight, BMI normal, overweight, obese) with baseline CD4+ T cells <200 cells/μL recovering to threshold.
(A) Cumulative risk rate of recovery of CD4+ T cells to ≥350 cells/μL in HIV-infected patients; (B) Cumulative risk rate of recovery of CD4+ T cells to ≥500 cells/μL in HIV-infected patients.
Table 3.
The associated factors of CD4+ T cell count recovery to the endpoints (≥ 350, 500 cells/μL).
Fig 4.
The fitting curve of viral load changes in different BMI categories (the black dotted line indicates that the viral load is 400 copies/ml; red dotted line indicates the 6th month of follow-up).